DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|4|379-399

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.4, 2013-05, pp. : 379-399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic cancer therapies: DNA methyltransferase inhibitors

By Brown Robert   Strathdee Gordon  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 747-754

Informa Healthcare

Access to resources Recommend Favorite

Histone Methyltransferase Inhibitors: Novel Epigenetic Agents for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 20, Iss. 2, 2013-01 ,pp. : 167-185

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 963-981

Bentham Science Publishers

Access to resources Recommend Favorite

Mammalian Cytosine DNA Methyltransferase Dnmt1: Enzymatic Mechanism, Novel Mechanism-Based Inhibitors, and RNA-directed DNA Methylation

By  

Current Medicinal Chemistry, Vol. 15, Iss. 1, 2008-01 ,pp. : 92-106

Bentham Science Publishers

Access to resources Recommend Favorite

DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies

By Fahy Jacques   Jeltsch Albert   Arimondo Paola B  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1427-1442

Informa Healthcare

Access to resources Recommend Favorite